Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))

Ting Chun Hung, Alagie Jassey, Ching Hsuan Liu, Chien Ju Lin, Chun Ching Lin, Shu Hui Wong, Jonathan Y. Wang, Ming Hong Yen, Liang Tzung Lin

研究成果: 雜誌貢獻評論/辯論同行評審

摘要

In P.67, Section BBR interacts with HCV envelope glycoprotein E2: "E1: 6.6 kcal/mol versus E2: 6.4 kcal/mol" should read "E1: −6.6 kcal/mol versus E2: −6.4 kcal/mol"; and "the highest binding energy of 6.7 kcal/mol" should read "the lowest binding energy of −6.7 kcal/mol".
原文英語
文章編號154128
期刊Phytomedicine
102
DOIs
出版狀態已發佈 - 7月 20 2022

ASJC Scopus subject areas

  • 分子醫學
  • 藥理
  • 藥學科學
  • 藥物發現
  • 補充和替代醫學

指紋

深入研究「Corrigendum to Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein (Phytomedicine (2019) 53 (62–69), (S0944711318303064), (10.1016/j.phymed.2018.09.025))」主題。共同形成了獨特的指紋。

引用此